Search bioRxiv⌕ Search

Biology subjects

Meszka, I.

Publications and source records attributed to Meszka, I..

2 recordsLinked to original sources

Co-aggregation of pre-conditioned cell populations drives controlled lineage bias and formation of gut tube-like structures in human stem cell-based embryo models

Human stem cell-based embryo models (hSCBEMs) provide a powerful platform for investigating post-implantation human embryo development but are frequently hindered by variability in growth and morphogenesis as well as incomplete lineage representations. Here, we present a modular hSCBEM aggregation approach based on co-aggregation of differentially pre-conditioned, human pluripotent stem cell derived cells pools. Using this strategy, we generated hSCBEM with consistent morphotypes that targets robust morphogenesis of gut tube-like structures in combination with mesodermal lineages. Our findings demonstrate that co-aggregating defined cellular heterogeneity represents a versatile approach to specifically guide self-organization in hSCBEMs while improving reproducibility and developmental fidelity. The approach provides a robust platform for supervised morphogenesis in hSCBEMs.

developmental biology↗

Targeting the deNEDDylating enzyme NEDP1 to ameliorate ALS phenotypes through Stress Granules dissolution

In Amyotrophic Lateral Sclerosis (ALS) motor neuron disease, mutations in proteins that upon stress localize within cytoplasmic protein inclusions called Stress Granules (SGs), are linked to the formation of aberrant inclusions, which are related to neuronal cell death. By combining studies in human cells and C. elegans including the use of Nanobodies, we found that inhibition of NEDP1, the enzyme responsible for the processing and deconjugation of the Ubiquitin-like molecule NEDD8 from substrates, promotes the elimination both of physiological and pathological SGs. The hyper-NEDDylation of Poly-(ADP-ribose) polymerase-1 enzyme upon NEDP1 inhibition compromises PAR production and is a key mechanism for the observed SG phenotype. Importantly, the above-described effects are related to improved cell survival in human cells, and in C. elegans, NEDP1 deletion ameliorates ALS-phenotypes related to animal motility. Our studies reveal NEDP1 as potential therapeutic target for ALS, based on the elimination of aberrant SGs.

cell biology↗